DOCK8 and B-cell chronic lymphocytic leukemia: To independently verify that DOCK8 interacts with Siglec-6, protein lysates from MEC1-002 or primary CD19+ CD5+ B-CLL cells were immunoprecipitated with the same Siglec-6 Ab that was used for the mass spectrometry analysis.